Clinical Epidemiology, Risk Factors, and Control Strategies of Klebsiella pneumoniae Infection
Клиническая эпидемиология, факторы риска и стратегии контроля инфекций, вызываемых Klebsiella pneumoniae
2021-12-21
SCID: 54.1/4ebwwyru
Discuss with AI
Carbapenem-resistant strainsClinical epidemiologyHypervirulent strainsKlebsiella pneumoniae infectionMultidrug-resistant infections
Figures from the paper
Abstract (AI)
Klebsiella species cause infections at multiple sites, including lung, urinary tract, bloodstream, wound or surgical site, and brain. These infections are more likely to occur in people with preexisting health conditions. Klebsiella pneumoniae (K. pneumoniae) has emerged as a major pathogen of international concern due to the increasing incidences of hypervirulent and carbapenem-resistant strains. It is imperative to understand risk factors, prevention strategies, and therapeutic avenues to treat multidrug-resistant Klebsiella infections. Here, we highlight the epidemiology, risk factors, and control strategies against K. pneumoniae infections to highlight the grave risk posed by this pathogen and currently available options to treat Klebsiella-associated diseases.
Key Findings
1
Effective management of multidrug-resistant K. pneumoniae requires understanding risk factors, prevention strategies, and therapeutic options.
2
Klebsiella pneumoniae infections occur more frequently in individuals with preexisting health conditions.
3
Klebsiella species cause infections across multiple sites, including the lungs, urinary tract, bloodstream, wounds, surgical sites, and brain.
4
The increasing incidence of hypervirulent and carbapenem-resistant K. pneumoniae strains has made this pathogen a major international health concern.
5
The review emphasizes the serious threat posed by K. pneumoniae and summarizes available control and treatment strategies for associated diseases.
Research Object
Klebsiella pneumoniae infections, including those caused by hypervirulent and carbapenem-resistant strains
Research Subject
Clinical epidemiology, risk factors, prevention and control strategies, and therapeutic options for K. pneumoniae infections
Publication Details
Publication Date
2021-12-21
Journal
Publisher
ISSN
Cited by
353
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America2019
Health care-associated infections – an overview2018
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)a2013